NO20064117L - Kjemisk prosess - Google Patents

Kjemisk prosess

Info

Publication number
NO20064117L
NO20064117L NO20064117A NO20064117A NO20064117L NO 20064117 L NO20064117 L NO 20064117L NO 20064117 A NO20064117 A NO 20064117A NO 20064117 A NO20064117 A NO 20064117A NO 20064117 L NO20064117 L NO 20064117L
Authority
NO
Norway
Prior art keywords
compound
formula
alkyl
approx
chemical process
Prior art date
Application number
NO20064117A
Other languages
English (en)
Inventor
Ulf Larsson
Kajsa Radevik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20064117L publication Critical patent/NO20064117L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for fremstilling av en forbindelse med formel (I): hvor X er halogen; Y er ZR1; Z er oksygen eller svovel; og R1 er C1-6-alkyl, C1-6-halogenalkyl eller C3-7-cykloalkyl; idet fremgangsmåten enten omfatter: hydrogenering en forbindelse med formel (II): med en egnet overgangsmetallkatalysator i en C1-6-alifatisk alkohol, en eter, en ester eller et hydrokarbon som løsningsmiddel; eller, b. å utføre en ett-kar-hydrogenering av en forbindelse med formel (III): hvor R2 er fenyl eventuelt substituert med klor, C1-6-alkyl, C1-6-alkoksy eller (C 1-8 alkyl)2N; og deretter ved ca. 40°C; først ved ca. 20°C for å danne en forbindelse med formel (IV):
NO20064117A 2004-03-31 2006-09-13 Kjemisk prosess NO20064117L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401001A SE0401001D0 (sv) 2004-03-31 2004-03-31 Chemical process
PCT/GB2005/001188 WO2005095358A2 (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines

Publications (1)

Publication Number Publication Date
NO20064117L true NO20064117L (no) 2006-10-30

Family

ID=32294337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064117A NO20064117L (no) 2004-03-31 2006-09-13 Kjemisk prosess

Country Status (23)

Country Link
US (2) US7799914B2 (no)
EP (2) EP1751117B1 (no)
JP (1) JP5059599B2 (no)
KR (1) KR101164265B1 (no)
CN (2) CN1938284B (no)
AT (1) ATE517096T1 (no)
AU (1) AU2005227727B2 (no)
BR (1) BRPI0509323A (no)
CA (1) CA2560094C (no)
CY (1) CY1111847T1 (no)
DK (1) DK1751117T3 (no)
ES (1) ES2368069T3 (no)
HR (1) HRP20110658T1 (no)
IL (1) IL177998A (no)
NO (1) NO20064117L (no)
NZ (2) NZ587999A (no)
PL (1) PL1751117T3 (no)
PT (1) PT1751117E (no)
SE (1) SE0401001D0 (no)
SG (1) SG151311A1 (no)
SI (1) SI1751117T1 (no)
WO (1) WO2005095358A2 (no)
ZA (1) ZA200607708B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
US8114996B2 (en) * 2006-02-13 2012-02-14 Lonza Ag Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine
RU2509082C2 (ru) 2008-09-09 2014-03-10 Астразенека Аб СПОСОБ ПОЛУЧЕНИЯ [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-ДИФТОРФЕНИЛ)-ЦИКЛОПРОПИЛАМИНО]-5-(ПРОПИЛТИО)-3H-1,2,3-ТРИАЗОЛО[4,5-d]ПИРИМИДИН-3-ИЛ]-5-(2-ГИДРОКСИЭТОКСИ)-ЦИКЛОПЕНТАН-1,2-ДИОЛА И ЕГО ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
EP2305376A1 (en) * 2009-09-23 2011-04-06 Lonza Ltd. Process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds
US9233966B2 (en) 2012-04-05 2016-01-12 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
CN103130726A (zh) * 2013-02-07 2013-06-05 许学农 替卡格雷中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
KR102325163B1 (ko) 2013-08-22 2021-11-11 제넨테크, 인크. 화합물의 제조 방법
CN103588712B (zh) * 2013-11-08 2016-06-08 南京欧信医药技术有限公司 一种嘧啶类化合物及其制备方法、和应用
CN103923020A (zh) * 2014-04-02 2014-07-16 黄河三角洲京博化工研究院有限公司 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法
CN105020602B (zh) * 2014-04-30 2017-12-08 欧普照明股份有限公司 一种led灯
CN103992277A (zh) * 2014-05-16 2014-08-20 苏州天马精细化学品股份有限公司 一种替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN105294573B (zh) * 2015-06-16 2018-07-10 厦门医学院 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法
CN116283796A (zh) * 2023-02-14 2023-06-23 上海汇伦医药股份有限公司 一种循环催化氢化硝基化合物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508687B1 (en) 1991-04-06 1995-09-13 Astra Pharmaceuticals Limited ATP analogues
ES2154825T3 (es) 1995-05-19 2001-04-16 Novartis Ag Procedimiento para la hidrogenacion catalitica de nitro compuestos aromaticos.
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US6818720B2 (en) * 2001-11-08 2004-11-16 Degussa Ag Supported hydrogenating catalyst in powder form
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process

Also Published As

Publication number Publication date
NZ587999A (en) 2012-04-27
HRP20110658T1 (hr) 2011-10-31
HK1103727A1 (en) 2007-12-28
EP2308853A1 (en) 2011-04-13
WO2005095358A3 (en) 2006-01-05
CN1938284A (zh) 2007-03-28
AU2005227727B2 (en) 2009-03-26
KR20060133019A (ko) 2006-12-22
WO2005095358A2 (en) 2005-10-13
NZ550128A (en) 2010-10-29
CN101851212A (zh) 2010-10-06
CA2560094A1 (en) 2005-10-13
ZA200607708B (en) 2008-06-25
CN1938284B (zh) 2010-08-11
KR101164265B1 (ko) 2012-07-09
ATE517096T1 (de) 2011-08-15
US20100324289A1 (en) 2010-12-23
CY1111847T1 (el) 2015-10-07
CA2560094C (en) 2012-10-30
US7799914B2 (en) 2010-09-21
IL177998A0 (en) 2006-12-31
BRPI0509323A (pt) 2007-09-04
PL1751117T3 (pl) 2011-11-30
PT1751117E (pt) 2011-09-19
JP2007530650A (ja) 2007-11-01
AU2005227727A1 (en) 2005-10-13
SI1751117T1 (sl) 2011-10-28
DK1751117T3 (da) 2011-10-10
SE0401001D0 (sv) 2004-03-31
SG151311A1 (en) 2009-04-30
JP5059599B2 (ja) 2012-10-24
EP1751117A2 (en) 2007-02-14
IL177998A (en) 2012-03-29
ES2368069T3 (es) 2011-11-14
US20070219371A1 (en) 2007-09-20
EP1751117B1 (en) 2011-07-20

Similar Documents

Publication Publication Date Title
NO20064117L (no) Kjemisk prosess
RU2009133453A (ru) Фторсодержащее пиразолкарбонитрильное производное и способ его получения и фторсодержащее производное пиразолкарбоновой кислоты, полученное с применением фторсодержащего пиразолкарбонитрильного производного и способ его получения
EA201390916A1 (ru) Новые ферроценовые метки для электрохимического анализа и их применение в аналитических способах
RU2010141941A (ru) Способ получения фторсодержащего производного ацилуксусной кислоты, способ получения фторсодержащего производного сложного эфира пиразолкарбоновой кислоты и способ получения фторсодержащего пиразолкарбоновой кислоты
RU2011133749A (ru) Способ получения и выделения 2-ациламино-3-дифенилпропионовой кислоты
RU2009113019A (ru) Способы получения 1,2,4-оксадиазолбензойных кислот
WO2007062542A3 (en) Process for the manufacture of epoxybutanol intermediates
DK1442006T3 (da) Fremstilling af amfetaminer fra phenylpropanolaminer
NO20075618L (no) Novel compounds as GLP-1 Agonists
AR059375A1 (es) Procedimiento para produccion de 5-alcoxi-4-hidroximetilpirazol y compuestos
RU2011144572A (ru) Стабильная при низких температурах биоцидная композиция
EA200601394A1 (ru) Способы получения 3-о-защищенных морфинов и 3-о-защищенных морфинондиенолкарбоксилатов
ECSP088115A (es) Procedimiento para la preparación de compuestos de 1-[ciano(4-hidroxifenil)metil]ciclohexanol
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
RU2013110311A (ru) Синтез соединений тиазолидиндиона
EA200701616A1 (ru) Способ получения промежуточных продуктов
EA200800633A1 (ru) Способ получения производных сартана и промежуточных соединений, пригодных для этого способа
DE602007002486D1 (de) Verfahren zur herstellung von 1-halogen-2,7-naphthyridinylderivaten
TW200619201A (en) Process for the preparation of pyrazoles
DE602006001394D1 (de) Verfahren zur herstellung einer vorstufe von vitamin b1
NO20074098L (no) Fremgangsmate for fremstilling av enantiomerisk rene 1-substituerte-3-aminoalkoholer
ATE531689T1 (de) Cycloalkyliden- (ortho-substituiertes phenyl)- acetonitrile und ihre verwendung als geruchsstoffe
DE602006005230D1 (de) Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten
DE602004022310D1 (de) Verfahren zur herstellung eines hochreinen 3,5-dihydroxy-6-heptensäurederivats
ITMI20041282A1 (it) Procedimento per la preparazione di imiquimod

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application